Ahead of Novo’s CagriSema readout, Lilly returns to a promising new class of obesity drugs
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Diagnoses of postpartum depression (PPD) increased significantly across all racial and ethnic groups and prepregnancy body mass index (BMI) categories over the past decade, according
GSK’s decision to switch patients from its brand-name Flovent inhaler to an authorized generic is an “insidious” tactic that “may cause millions of children” to